in

Blue Horseshoe Stocks: Bottom-Bouncers & More

 


North Atlantic Drilling Ltd. NADL

We've got an array of potential bottom-bounce plays to go over this morning, the first of which is NADL. This stock has been getting beaten down incrementally since reaching a high of 4.80 in December. It's been one selloff after another since then, culminating in a low of .65 during yesterday's session. 

We're seeing a moderate gap-up this morning, and want to put NADL on our watchlist moving forward on the chance that a multi-day rebound is on the way.  

__________

Catalyst BioSciences, Inc. CBIO

Next up on our bottom-bounce watchlist is CBIO, which is also gapping up off of a bottom in the premarket this morning with the help of a key press release, of which we'll include a snippet below.

The stock recently made a massive run to the $18, so the potential for another major move is certainly present.

SOUTH SAN FRANCISCO, Calif., April 11, 2017 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc., (Nasdaq:CBIO) a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced that it has achieved a key milestone under its collaboration with ISU Abxis to advance the Factor IX program towards its first human clinical trial. Completion of the CB 2679d/ISU304 toxicology studies supported the recent Investigational New Drug (IND) approval by the Korean Ministry of Food and Drug Safety (MFDS) and triggered a milestone payment to Catalyst. (>>View Full PR)
__________

Sunshine Heart, Inc. SSH

We tagged SSH as a bottom play a week ago today on the 4th, and subsequently tracked it over a pretty nice run last week as it traded up from 1.67 and hit 2.25 (+35%). It pulled back to the low 1.70's yesterday and appears to be gearing up for another possible move.

Just two months ago the stock was trading at more than $5/share, so we wanted to add a little reminder this morning that SSH could be line for an extended recovery that we'll want to look out for in the day and weeks ahead.
 


Galectin Therapeutics, Inc. GALT

We were just mentioning yesterday morning the excellent move from GALT we had witnessed between first bringing it up in January and the present. The run, originating at a low of .935 had already reached just beyond the 200% level, and after a very nice intraday performance, our observed range was extended even further.

Trading up from a morning low to 2.75, the stock traded up 34% to reach 3.68. That pushed the overall percentage gain we've witnessed in GALT for 2017 to a highly respectable 294% 
 


Extended Watchlist:
AMLH, SALE, GLBS, AKER, STAF

 Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Our disclaimer is to be read and fully agreed to before using our site, or joining our email list. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions, however any that may occur will be corrected as needed. BHS and its affiliates are not registered or licensed investment advisers, nor broker dealers. BHS cautions that the investments in companies profiled are commonly considered to be extremely high risk and use of any information provided is at the investor's sole risk.

Copyright © 2017 Bullinadvantage.com, All rights reserved.
 

WE USE AND FULLY ENDORSE:
EquityFeed
CLICK TO SIGN UP TODAY!

 

Related Post

It’s Time to Buy Some Portfolio Insurance

The Daily Update from The Disciplined Investor